about
Genotype-phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathyThe bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial--BARTrialDoes naltrexone affect craving in abstinent opioid-dependent patients?Quality of life as an outcome measure in surgical oncology.The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.Assessment of vaccine candidates for persons aged 50 and older: a review.Quality of life in dementia: a study on proxy biasAre patients' judgments of health status really different from the general population?A generalized measurement model to quantify health: the multi-attribute preference response modelQuantification of health by scaling similarity judgments.Randomised controlled trial of the effect of ventilation tubes (grommets) on quality of life at age 1-2 yearsA multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA).Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.Quality of life in adults with childhood-onset of Complex Regional Pain Syndrome type I.Probabilistic choice models in health-state valuation research: background, theories, assumptions and applications.Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale.Discrete choice modeling for the quantification of health states: the case of the EQ-5D.A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia.Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence.Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.Validation of a frailty index from the older persons and informal caregivers survey minimum data set.Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.High abstinence rates in heroin addicts by a new comprehensive treatment approach.Prediction of withdrawal symptoms during opioid detoxification.Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.Opioid detoxification: from controlled clinical trial to clinical practice.General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: a randomized controlled trial.Prediction of abstinence in opioid-dependent patients.Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies.Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.The effect of treatment on quality of life in psoriasis patients.A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation.The development of new research methods for the valuation of EQ-5D-5L.
P50
Q28253929-9B90BC7A-A400-4DAD-8A20-BAF7684B410BQ33753683-838D06FA-4421-4CEA-ACFA-B937C1F35D5FQ34004211-271FE439-8669-486E-A162-CDDB767D089FQ34249655-D77DE9E0-20C7-48BC-B487-9153ECA44947Q34471196-5E7300B3-D439-413E-9169-FAB0DA989E0BQ34668826-16B9BEF2-DCBA-4119-A10A-BEEEC2828ED0Q34980539-07300427-66E9-43AE-B0F0-C316A8386FB4Q35042053-B80F82EA-046F-4124-8CA6-0A7FA4D5EB3CQ35053174-49DABB5A-6C67-417B-8915-B8ECAA5281F5Q35106658-4136A495-EAAB-4C2C-BBEF-E0CFE59A8A35Q35268466-C4A60BB0-A275-446A-9EDC-37C8606BB10AQ36083140-621AE409-720A-4386-9C3D-130838DC900CQ36591016-E1810CB0-7CFC-4B48-B20A-5C5632CE4E0FQ37518749-AFAF2C9A-C07C-4C18-945B-EC783C49158BQ38080918-BE564CEA-4B51-4E51-A89B-65B54428C0E2Q39222173-F517CE89-E552-456C-82DB-01B1BC7F71E0Q39839843-7724E12C-8CDF-46D1-BAC2-E4FA97CC0615Q40203315-7E7FF50F-D841-4AD1-A8AB-593455DA0F83Q40252023-20070B77-68DF-4085-8A8D-A48D8E6B1892Q40294131-95C108AC-54B5-4AB2-82E2-3AD1606B3AD8Q42590895-14F5FD49-A7E3-4B98-9B3B-075F2B43A1DFQ42882232-976A2318-8098-415F-B8F7-3BADE684EAAEQ42957426-9BBE5062-9516-4637-819A-C59FBDF46086Q43259557-779CE10A-8CA9-497E-A8E7-4F8D1FA20C2EQ43607626-5A9718B6-959E-4D9D-96EF-8A9D4CB9BF57Q43683228-77C6A9F8-A2E3-48B9-A2DB-5B724A3FDA0DQ43966467-91B42AF7-0570-4043-BD96-93528E9FB026Q43988580-AD5504E4-0665-4552-AA37-CD690F0A6CBCQ44342835-5193F71B-884D-400D-B7AA-4BFB0B6B1679Q44346731-1E92A015-1271-4555-B3D0-3EDC8D2BBA44Q44347899-9B7A1F99-64FE-42DF-9F19-B20C881D020CQ44351688-ACDEA36A-7F67-4AE5-9911-45832E6C6B46Q45969787-47C0965D-A7E5-4D39-AB73-E10DC1843625Q46020983-ED826A80-1F18-4351-A9C0-C2097FF39CFCQ46605109-C43F40E6-7D9C-4945-9C94-C230BECFC03DQ46726434-30B46C51-010E-4FE1-B8E7-65352CB15B8BQ46861089-CEB9E48F-C0DD-4006-8FE7-264E2C4A68AEQ46930593-28F935CD-05D1-4507-AF10-E137F3C0442FQ47337572-D0683F10-06C6-4D0C-AE4F-2B285CAF4FEAQ48191400-AA6F0AD0-BF48-48ED-B723-4FC75B45D4FB
P50
subject
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Paul Krabbe
@ast
Paul Krabbe
@en
Paul Krabbe
@es
Paul Krabbe
@nl
Paul Krabbe
@sl
type
label
Paul Krabbe
@ast
Paul Krabbe
@en
Paul Krabbe
@es
Paul Krabbe
@nl
Paul Krabbe
@sl
altLabel
Krabbe, P.F.
@en
P.F.M. Krabbe
@en
prefLabel
Paul Krabbe
@ast
Paul Krabbe
@en
Paul Krabbe
@es
Paul Krabbe
@nl
Paul Krabbe
@sl
P1006
P214
P244
P1006
P106
P1153
6701715158
P21
P214
P244
P31
P496
0000-0001-6042-1243
P734
P735
P7859
lccn-n93024641